These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8354301)
1. Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections. Pérez-Trallero E; Urbieta M; Jimenez D; García-Arenzana JM; Cilla G Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):349-51. PubMed ID: 8354301 [TBL] [Abstract][Full Text] [Related]
2. [Quinolone resistance of Escherichia coli strains isolated from urinary tract infections]. Agulla A; Montes I Enferm Infecc Microbiol Clin; 1994; 12(6):322. PubMed ID: 8080877 [No Abstract] [Full Text] [Related]
3. [Quinolone-resistant Escherichia coli in the health area of a 650-bed hospital]. Fernández Fernández A; Lantero Benedito M; Gastañares Hernando MJ; Undabeitia Santisteban E; Fernández Santos F; Castaño Rodríguez A; Gil Fabra J; Martínez Castellanos F; Otero Mauricio G Actas Urol Esp; 1994 Jun; 18(6):634-8. PubMed ID: 7942213 [TBL] [Abstract][Full Text] [Related]
4. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice. Obana Y; Nishino T Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182 [TBL] [Abstract][Full Text] [Related]
5. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections]. Tuchiluş C; Poiată A; Bădicuţ I; Buiuc D Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):383-6. PubMed ID: 16607805 [TBL] [Abstract][Full Text] [Related]
7. Sequential mutations of gyrA in Escherichia coli associated with quinolone therapy. Truong QC; Ouabdesselam S; Hooper DC; Moreau NJ; Soussy CJ J Antimicrob Chemother; 1995 Dec; 36(6):1055-9. PubMed ID: 8821606 [TBL] [Abstract][Full Text] [Related]
8. Increasing incidence of quinolone-resistant E. coli from urinary cultures in Ankara-Pursaklar region. Tekin O; Catal F; Ibýk B; Açýkgöz ZC Int J Antimicrob Agents; 2004 Apr; 23(4):416-7. PubMed ID: 15081097 [No Abstract] [Full Text] [Related]
9. Norfloxacin versus pipemidic acid in complicated urinary tract infections due to susceptible pathogens: a comparative clinical trial. Del Favero A; Frongillo RF; Menichetti F; Boldrini F; Guerciolini R; Pauluzzi S Chemioterapia; 1986 Apr; 5(2):88-91. PubMed ID: 3518966 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species. Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396 [TBL] [Abstract][Full Text] [Related]
11. Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates. Lin CY; Huang SH; Chen TC; Lu PL; Lin WR; Chen YH J Microbiol Immunol Infect; 2008 Aug; 41(4):325-31. PubMed ID: 18787740 [TBL] [Abstract][Full Text] [Related]
12. Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands. Goettsch W; van Pelt W; Nagelkerke N; Hendrix MG; Buiting AG; Petit PL; Sabbe LJ; van Griethuysen AJ; de Neeling AJ J Antimicrob Chemother; 2000 Aug; 46(2):223-8. PubMed ID: 10933644 [TBL] [Abstract][Full Text] [Related]
18. Association between fluoroquinolone resistance and resistance to other antimicrobial agents among Escherichia coli urinary isolates in the outpatient setting: a national cross-sectional study. Hwang TJ; Hooper DC J Antimicrob Chemother; 2014 Jun; 69(6):1720-2. PubMed ID: 24521853 [No Abstract] [Full Text] [Related]
19. Frequency and expression of mutational resistance to the 4-quinolone antibacterials. Smith JT Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618 [TBL] [Abstract][Full Text] [Related]
20. Resistance to quinolones in pathogens causing urinary tract infections. Kapoor H; Aggarwal P J Commun Dis; 1997 Sep; 29(3):263-7. PubMed ID: 9465532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]